-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
KalVista Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2014 to 2023.
- KalVista Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending July 31, 2023 was $193 K, a 22.2% increase year-over-year.
- KalVista Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $718 K, a 27.3% increase from 2021.
- KalVista Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $564 K, a 5.03% increase from 2020.
- KalVista Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2020 was $537 K, a 4.88% increase from 2019.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)